SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.19 CNY | +1.35% |
|
+3.02% | -7.35% |
| 04-24 | Fosun Pharma Unit Gets Marketing Registration Approval for Tuberculosis Drug from Chinese Regulator | MT |
| 04-18 | China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy | MT |
Chart calendar Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
100475a2a.iMP-jUXcbWXqo556deHxhd9hbKqS56-CauJMj0g3WRc.u4yJ_HysARakz64wPISQzqYYLtvQsubxWLci3zpQIWXgk8jUKLIJHK3Z2w~9f4816ff7dfb2ae05a39af4f2b3ba7ff
Upcoming events on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Past events on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| 26/03/2024 | Q4 2023 Earnings Call |
| 26/03/2024 13:29 | Q4 2023 Earnings Release |
| 29/10/2023 | Q3 2023 Earnings Release |
| 13/10/2023 06:30 | Extraordinary Shareholders Meeting |
| 28/08/2023 | Q2 2023 Earnings Release |
| 08/08/2023 | Ex-dividend day for final dividend |
| 28/06/2023 06:00 | Annual General Meeting |
| 05/06/2023 | BIO International Convention |
| 09/05/2023 | BEYOND International Technology Innovation Expo |
| 27/04/2023 | Q1 2023 Earnings Release |
| 27/03/2023 | Q4 2022 Earnings Release |
| 29/11/2022 05:30 | Extraordinary Shareholders Meeting |
| 29/10/2022 | Q3 2022 Earnings Release |
| 07/09/2022 | Interim 2022 Earnings Call |
| 29/08/2022 15:39 | Interim 2022 Earnings Release |
| 10/08/2022 06:30 | Extraordinary Shareholders Meeting |
| 15/06/2022 | Ex-dividend day for final dividend |
| 01/06/2022 06:00 | Annual General Meeting |
| 25/04/2022 | Q1 2022 Earnings Release |
| 22/03/2022 | FY 2021 Earnings Call |
Past dividends on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| 08/08/2023 | Annual 0.42 CNY |
| 15/06/2022 | Annual 0.56 CNY |
| 18/07/2021 | Annual 0.43 CNY |
| 29/07/2020 | Annual 0.39 CNY |
| 01/08/2019 | Annual 0.32 CNY |
| 02/08/2018 | Annual 0.38 CNY |
| 08/08/2017 | Annual 0.35 CNY |
| 22/06/2016 | Annual 0.32 CNY |
| 11/08/2015 | Annual 0.28 CNY |
| 18/08/2014 | Annual 0.27 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 28 585 28 872 -0.99% | 30 307 32 997 -8.15% | 39 005 36 588 6.61% | 43 952 44 831 -1.96% | 41 400 41 589 -0.46% | 45 054 |
|
EBITDA Million CNY | Released Forecast Spread | 5 874 3 780 55.4% | 6 282 4 732 32.74% | 8 105 5 208 55.63% | 6 889 6 310 9.18% | 6 160 4 842 27.22% | 7 009 |
|
EBIT Million CNY | Released Forecast Spread | 4 494 2 613 71.95% | 4 721 3 879 21.72% | 6 314 3 230 95.46% | 4 657 4 284 8.69% | 3 308 1 915 72.68% | 3 603 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 4 526 4 527 -0.03% | 4 678 4 901 -4.55% | 6 054 5 866 3.21% | 4 574 5 099 -10.29% | 3 265 4 414 -26.04% | 4 699 |
|
Net income Million CNY | Released Forecast Spread | 3 322 3 337 -0.45% | 3 663 3 531 3.72% | 4 735 4 467 6% | 3 731 3 769 -1.01% | 2 386 3 373 -29.26% | 3 342 |
|
EPS CNY | Released Forecast Spread | 1,30 1,32 -1.22% | 1,43 1,40 2.43% | 1,85 1,74 6.04% | 1,43 1,52 -6.04% | 0,89 1,24 -28.41% | 1,26 |
| Announcement Date | 30/03/20 | 29/03/21 | 22/03/22 | 27/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 11 957 11 821 1.15% | 10 382 9 609 8.04% | 10 893 10 623 2.54% | 10 270 10 045 2.24% | 12 341 12 561 -1.75% | 10 871 10 535 3.19% | 10 445 11 338 -7.88% | 9 305 10 612 -12.32% | 10 699 9 734 9.92% | 10 691 | 10 814 | 10 631 | 11 295 |
|
EBIT Million CNY | Released Forecast Spread | 1 615 1 003 60.93% | 863 819 5.4% | 1 136 691 64.4% | 1 046 1 020 2.49% | 1 064 1 267 -15.98% | 1 427 1 105 29.15% | 1 255 926 35.58% | 660 927 -28.85% | -34,7 843 -104.12% | 655 | 518 | 875 | 677 |
|
EPS CNY | Released Forecast Spread | 0,46 0,34 35.29% | 0,18 0,33 -45.45% | 0,42 0,43 -1.18% | 0,35 0,41 -13.58% | 0,48 0,38 28% | 0,37 0,38 -2.63% | 0,30 0,33 -7.69% | 0,19 0,39 -51.28% | 0,04 0,41 -90.12% | 0,27 | 0,31 | 0,46 | 0,43 |
| Announcement Date | 22/03/22 | 26/04/22 | 29/08/22 | 30/10/22 | 27/03/23 | 28/04/23 | 29/08/23 | 30/10/23 | 26/03/24 | - | - | - | - |
More events
Past sector events for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600196 Stock
- Calendar Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
